The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Topic summary

Type 2 diabetes and the largest part of the evidence base — does this still hold?

This is a generated summary. It shows the 5 most-liked posts from a topic of 23, in their original order, with the accepted answer included where one exists. It is a reading aid and it will miss nuance — the full topic is the record.
VB
v.bhattacharyaTL2 Moderator4 Apr 2026#3
e.almeida, post #1: Type 2 diabetes and the largest part of the evidence base — does this still hold? I have a specific reason for asking rather than idle curiosity, and the context is below. Asking about a population rather than about a person. The published trials in this class mostly enrolled a fairly specific group, and the questions here frequently… Go to post

Two things before anyone answers the substance.

First, the context in the first post is clear and specific. Second, the question is framed so that an answer can actually address it. Both are the norm here and both matter more than they sound.

26 likes in reply to #1 4mo
FF
f.fonsecaTL2 Moderator Solution8 May 2026#8

PCOS and metabolic overlap: polycystic ovary syndrome has metabolic overlap with obesity and insulin resistance. Data on compounds in this class in PCOS specifically is thin; most discussion is by mechanism.

8 likes 3mo
EC
excursion_checkTL3Regular12 Jun 2026#14

Type 2 diabetes: the population with the largest evidence base for these compounds. The SURPASS and SUSTAIN programmes established glycaemic benefit. The renal and cardiovascular benefit evidence is separate from the glycaemic benefit evidence.

31 likes 2mo
P
PSkarbekTL3Regular2 Jul 2026#18

Two things before anyone answers the substance.

First, the context in the first post is clear and specific. Second, the question is framed so that an answer can actually address it. Both are the norm here and both matter more than they sound.

23 likes 26d
IA
i.amankwahTL2 Moderator7 Jul 2026 · edited#19

post #18 answers the question as asked. The question underneath it is different.

For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.

32 likes 21d

Read the full topic (23 posts)

Suggested topics

TopicParticipantsRepliesViewsActivity
Hypertension improvement and when medication needs revisiting — a second dataset
Posting this under the heading it deserves: Hypertension improvement and when medication needs revisiting — a second dataset Everything below is what sits behind that. General question, not a request for…
RMKBMMSCDT+126 133 22k 21mo
Obstructive sleep apnoea and a hard endpoint in this class
On the subject in the title: Obstructive sleep apnoea and a hard endpoint in this class Working notes rather than a conclusion. Asking about a population rather than about a person. The published trials in…
OBFATWAKMS+120 129 1.8k 13mo
Revisiting: Heart failure with preserved ejection fraction: symptom endpoints
On the subject in the title: Revisiting: Heart failure with preserved ejection fraction: symptom endpoints Working notes rather than a conclusion. General question, not a request for advice about my own care…
SPDBOCASCN+4 8 43k 17mo
Cardiovascular risk: reading the outcome trials as a set
Cardiovascular risk: reading the outcome trials as a set Writing it up because I had to work it out twice and would rather nobody else did. Asking about a population rather than about a person. The published…
JMVKEFHJKB 4 12k 5mo
[2026 update] Gastro-oesophageal reflux: improving or worsening?
Asking directly, because I could not find a straight answer: Gastro-oesophageal reflux: improving or worsening? General question, not a request for advice about my own care — I know the difference and I would…
EFFIMDN 3 782 13mo

Related topics — sharing the tags type 2 diabetes, chronic kidney disease, PCOS

TopicParticipantsRepliesViewsActivity
Asking about a compound your prescriber has not heard of — one year on
On the subject in the title: Asking about a compound your prescriber has not heard of — one year on Working notes rather than a conclusion. General question, not a request for advice about my own care — I…
ESMHKDOBSG+11 15 3.7k 19mo
What a good consultation looks like from the other side
What a good consultation looks like from the other side — that is the question, and I have not found it answered plainly anywhere I have looked. Asking about a population rather than about a person. The…
KFDFIBKPS+57 62 4.9k 22h
Adolescents: a distinct evidence base — one year on
Posting this under the heading it deserves: Adolescents: a distinct evidence base — one year on Everything below is what sits behind that. General question, not a request for advice about my own care — I know…
NIGHNCVEF+78 88 9.3k 3mo
Heart failure with preserved ejection fraction: symptom endpoints
Heart failure with preserved ejection fraction: symptom endpoints — setting out what I have, and where I think it stops being reliable. Asking about a population rather than about a person. The published…
ITSGSRFVII+19 23 311 12d
What to bring: records that a clinician can actually use
Asking directly, because I could not find a straight answer: What to bring: records that a clinician can actually use Asking about a population rather than about a person. The published trials in this class…
ATAPCLAIPM+15 19 6.4k 1d